-
1
-
-
33845404677
-
Thiolated Chitosan/DNA Nanocomplexes Exhibit Enhanced and Sustained Gene Delivery
-
D. Lee, W. Zhang, and S. Shirley Thiolated Chitosan/DNA Nanocomplexes Exhibit Enhanced and Sustained Gene Delivery Pharm Res 24 2007 157
-
(2007)
Pharm Res
, vol.24
, pp. 157
-
-
Lee, D.1
Zhang, W.2
Shirley, S.3
-
2
-
-
33745686074
-
Improvement of pulmonary hypoplasia associated with congenital diaphragmatic hernia by in utero CFTR gene therapy
-
J.E. Larson, and J.C. Cohen Improvement of pulmonary hypoplasia associated with congenital diaphragmatic hernia by in utero CFTR gene therapy Am J Physiol Lung Cell Mol Physiol 291 2006 L4
-
(2006)
Am J Physiol Lung Cell Mol Physiol
, vol.291
, pp. 4
-
-
Larson, J.E.1
Cohen, J.C.2
-
3
-
-
40949120900
-
Full-length dystrophin gene transfer to the MDX mouse in utero
-
D.P. Reay, R. Bilbao, and B. Koppanati Full-length dystrophin gene transfer to the MDX mouse in utero Gene Ther 7 2008 531
-
(2008)
Gene Ther
, vol.7
, pp. 531
-
-
Reay, D.P.1
Bilbao, R.2
Koppanati, B.3
-
4
-
-
34547416185
-
Fetal gene therapy of α-thalassemia in a mouse model
-
X.D. Han, C. Lin, and J. Chang Fetal gene therapy of α-thalassemia in a mouse model PNAS 104 2007 9007
-
(2007)
PNAS
, vol.104
, pp. 9007
-
-
Han, X.D.1
Lin, C.2
Chang, J.3
-
5
-
-
0142089747
-
Fatal systemic inflammatory response syndrome in an ornithine transcarbamylase deficient patient following adenoviral gene transfer
-
S.E. Raper, N. Chirmule, and F.S. Lee Fatal systemic inflammatory response syndrome in an ornithine transcarbamylase deficient patient following adenoviral gene transfer Mol Genet Metab 80 2003 148
-
(2003)
Mol Genet Metab
, vol.80
, pp. 148
-
-
Raper, S.E.1
Chirmule, N.2
Lee, F.S.3
-
6
-
-
33646361846
-
Gene therapy: Therapeutic gene causing lymphoma
-
N.B. Woods, V. Bottoro, and M. Schmidt Gene therapy: Therapeutic gene causing lymphoma Nature 440 2006 1123
-
(2006)
Nature
, vol.440
, pp. 1123
-
-
Woods, N.B.1
Bottoro, V.2
Schmidt, M.3
-
7
-
-
0031714427
-
Chitosan: A unique polysaccharide for drug delivery
-
O. Felt, P. Buri, and R. Gurny Chitosan: A unique polysaccharide for drug delivery Drug Dev Ind Pharm 24 1998 979
-
(1998)
Drug Dev Ind Pharm
, vol.24
, pp. 979
-
-
Felt, O.1
Buri, P.2
Gurny, R.3
-
8
-
-
0035937594
-
Mucoadhesive nonparticulate systems for peptide drug delivery
-
H. Takeuchi, Y. Yamamoto, and Kawashima Mucoadhesive nonparticulate systems for peptide drug delivery Adv Drug Deliv Rev 47 2001 39
-
(2001)
Adv Drug Deliv Rev
, vol.47
, pp. 39
-
-
Takeuchi, H.1
Yamamoto, Y.2
Kawashima3
-
9
-
-
0142119203
-
Polyethylamine-based gene therapy by inhalation
-
C.L. Densmore Polyethylamine-based gene therapy by inhalation Expert Opin Biol Ther 3 2003 1083
-
(2003)
Expert Opin Biol Ther
, vol.3
, pp. 1083
-
-
Densmore, C.L.1
-
10
-
-
0035813684
-
Chitosans for gene delivery
-
G. Borchard Chitosans for gene delivery Adv Drug Deliv Rev 52 2001 145
-
(2001)
Adv Drug Deliv Rev
, vol.52
, pp. 145
-
-
Borchard, G.1
-
11
-
-
42149116854
-
Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue
-
M. De la Fuente, B. Seijo, and M.J. Alonso Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue Gene Ther 15 2008 668
-
(2008)
Gene Ther
, vol.15
, pp. 668
-
-
De La Fuente, M.1
Seijo, B.2
Alonso, M.J.3
-
12
-
-
53549123567
-
Characterization of chitosan-coated vesicles encapsulating DNA suitable for gene delivery
-
L. Kudsiova, C. Arafiena, and M.J. Lawrence Characterization of chitosan-coated vesicles encapsulating DNA suitable for gene delivery J Pharm Sci 97 2008 3981
-
(2008)
J Pharm Sci
, vol.97
, pp. 3981
-
-
Kudsiova, L.1
Arafiena, C.2
Lawrence, M.J.3
-
13
-
-
39449125413
-
Combination of poly(ethylenimine) and chitosan induces high gene transfection efficiency and low cytotoxicity
-
Q.Q. Zhao, J.L. Chen, and M. Han Combination of poly(ethylenimine) and chitosan induces high gene transfection efficiency and low cytotoxicity J Biosci Bioeng 105 2008 65
-
(2008)
J Biosci Bioeng
, vol.105
, pp. 65
-
-
Zhao, Q.Q.1
Chen, J.L.2
Han, M.3
-
14
-
-
58149190649
-
Chitosan as a carrier for non viral gene transfer in a cystic fibrosis cell line
-
Feb 21 [epub ahead of print]
-
P. Nydert, A. Dragomir, and L. Hjelte Chitosan as a carrier for non viral gene transfer in a cystic fibrosis cell line Biotechnol Appl Biochem 51 2008 153 Feb 21 [epub ahead of print]
-
(2008)
Biotechnol Appl Biochem
, vol.51
, pp. 153
-
-
Nydert, P.1
Dragomir, A.2
Hjelte, L.3
-
15
-
-
44449157661
-
Hydrophobically modified low molecular weight chitosans as efficient and nontoxic gene delivery vectors
-
X. Zhang, S. Ercelen, and G. Duportail Hydrophobically modified low molecular weight chitosans as efficient and nontoxic gene delivery vectors J Gene Med 10 2008 527
-
(2008)
J Gene Med
, vol.10
, pp. 527
-
-
Zhang, X.1
Ercelen, S.2
Duportail, G.3
-
16
-
-
10744227749
-
Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: A multicenter, double blind, placebo-controlled trial
-
R.B. Moss, D. Rodman, and L.T. Spencer Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: A multicenter, double blind, placebo-controlled trial Chest 125 2004 509
-
(2004)
Chest
, vol.125
, pp. 509
-
-
Moss, R.B.1
Rodman, D.2
Spencer, L.T.3
-
17
-
-
0034779927
-
A phase i study of aerosolized administration of tgAAVCF to cystic fibrosis patients with mild lung disease
-
M.L. Aitken, R.B. Moss, and D.A. Waltz A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis patients with mild lung disease Hum Gene Ther 12 2001 1907
-
(2001)
Hum Gene Ther
, vol.12
, pp. 1907
-
-
Aitken, M.L.1
Moss, R.B.2
Waltz, D.A.3
-
18
-
-
0036377851
-
A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF used maxillary sinus delivery in patients with cystic fibrosis with antrostomies
-
J.A. Wagner, I.B. Nepumuceno, and A.H. Messner A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF used maxillary sinus delivery in patients with cystic fibrosis with antrostomies Hum Gene Ther 13 2002 1349
-
(2002)
Hum Gene Ther
, vol.13
, pp. 1349
-
-
Wagner, J.A.1
Nepumuceno, I.B.2
Messner, A.H.3
-
19
-
-
0038488551
-
Phase i trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: A two-part clinical study
-
T.R. Flotte, P.L. Zeitlin, and T.C. Reynolds Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: A two-part clinical study Hum Gene Ther 14 2003 1079
-
(2003)
Hum Gene Ther
, vol.14
, pp. 1079
-
-
Flotte, T.R.1
Zeitlin, P.L.2
Reynolds, T.C.3
-
20
-
-
23844498432
-
Correlation between DNA transfer and cystic fibrosis airway epithelial cell correction after recombinant adeno-associated virus serotype 2 gene therapy
-
T.R. Flotte, E.M. Schwiebert, and P.L. Zeitlin Correlation between DNA transfer and cystic fibrosis airway epithelial cell correction after recombinant adeno-associated virus serotype 2 gene therapy Hum Gene Ther 16 2005 921
-
(2005)
Hum Gene Ther
, vol.16
, pp. 921
-
-
Flotte, T.R.1
Schwiebert, E.M.2
Zeitlin, P.L.3
-
21
-
-
44949229208
-
Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease
-
vol 3
-
T. Lee, and K.W. Southern Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease The Cochrane Database of Systematic Reviews 2007 vol 3
-
(2007)
The Cochrane Database of Systematic Reviews
-
-
Lee, T.1
Southern, K.W.2
-
22
-
-
0036664804
-
Delivery of gene transfer vectors to lung: Obstacles and the role of adjunct techniques for airway administration
-
D.J. Weiss Delivery of gene transfer vectors to lung: Obstacles and the role of adjunct techniques for airway administration Mol Ther 6 2002 148
-
(2002)
Mol Ther
, vol.6
, pp. 148
-
-
Weiss, D.J.1
-
23
-
-
5444264363
-
Gene therapy for cystic fibrosis: An example of lung gene therapy
-
U. Griesenbach, D.M. Geddes, and E.W.F.W. Alton Gene therapy for cystic fibrosis: An example of lung gene therapy Gene Ther 11 2004 S43
-
(2004)
Gene Ther
, vol.11
, pp. 43
-
-
Griesenbach, U.1
Geddes, D.M.2
Alton, E.W.F.W.3
-
24
-
-
33645923713
-
Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors
-
C.L. Halbert, A.D. Miller, and S. McNamara Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors Hum Gene Ther 17 2006 440
-
(2006)
Hum Gene Ther
, vol.17
, pp. 440
-
-
Halbert, C.L.1
Miller, A.D.2
McNamara, S.3
-
25
-
-
24644507123
-
Gastric emptying cycles in the human fetus
-
M. Sase, I. Miwa, and M. Sumie Gastric emptying cycles in the human fetus Am J Obstet Gynecol 193 2005 1000
-
(2005)
Am J Obstet Gynecol
, vol.193
, pp. 1000
-
-
Sase, M.1
Miwa, I.2
Sumie, M.3
-
26
-
-
38649118552
-
Why Bother? Is in utero gene therapy worth the effort?
-
C. Coutelle Why Bother? Is in utero gene therapy worth the effort? Mol Ther 16 2008 219
-
(2008)
Mol Ther
, vol.16
, pp. 219
-
-
Coutelle, C.1
-
27
-
-
0141731365
-
Ethics: "life before birth" and moral complexity in maternal-fetal surgery for spina bifida
-
M.J. Bliton Ethics: "Life before birth" and moral complexity in maternal-fetal surgery for spina bifida Clin Perinatol 30 2003 449
-
(2003)
Clin Perinatol
, vol.30
, pp. 449
-
-
Bliton, M.J.1
-
28
-
-
34250688728
-
In vitro gene delivery to HepG2 cells using galactosylated 6-amino-6-deoxychitosan as a DNA carrier
-
T. Satoh, S. Kakimoto, and H. Kano In vitro gene delivery to HepG2 cells using galactosylated 6-amino-6-deoxychitosan as a DNA carrier Carbohydr Res 342 2007 1427
-
(2007)
Carbohydr Res
, vol.342
, pp. 1427
-
-
Satoh, T.1
Kakimoto, S.2
Kano, H.3
-
29
-
-
41949130229
-
Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-rasLA1 mice
-
H. Jin, C.X. Xu, and H.W. Kim Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-rasLA1 mice Cancer Gene Ther 15 2008 275
-
(2008)
Cancer Gene Ther
, vol.15
, pp. 275
-
-
Jin, H.1
Xu, C.X.2
Kim, H.W.3
-
30
-
-
34250159823
-
Chitosan-thioglycolic acid conjugate: An alternative carrier for oral non-viral gene delivery?
-
R. Martien, B. Loretz, and M. Thaler Chitosan-thioglycolic acid conjugate: An alternative carrier for oral non-viral gene delivery? J Biomed Mater Res A 82 2007 1
-
(2007)
J Biomed Mater Res A
, vol.82
, pp. 1
-
-
Martien, R.1
Loretz, B.2
Thaler, M.3
-
31
-
-
0035424424
-
In vitro gene delivery mediated by chitosan. Effect of pH, serum and molecular mass of chitosan on the transfection efficiency
-
T. Sato, T. Ishii, and Y. Okahata In vitro gene delivery mediated by chitosan. Effect of pH, serum and molecular mass of chitosan on the transfection efficiency Biomaterials 22 2001 2075
-
(2001)
Biomaterials
, vol.22
, pp. 2075
-
-
Sato, T.1
Ishii, T.2
Okahata, Y.3
-
32
-
-
0035936972
-
Chitosan-DNA nanoparticles as gene carriers: Synthesis, characterization and transfection efficiency
-
H.Q. Mao, K. Roy, and V. Troung-Le Chitosan-DNA nanoparticles as gene carriers: Synthesis, characterization and transfection efficiency J Control Release 70 2001 399
-
(2001)
J Control Release
, vol.70
, pp. 399
-
-
Mao, H.Q.1
Roy, K.2
Troung-Le, V.3
-
33
-
-
0034786764
-
Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo
-
M. Koping-Hoggard, I.T. Guan, and K. Edwards Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo Gene Ther 8 2001 1108
-
(2001)
Gene Ther
, vol.8
, pp. 1108
-
-
Koping-Hoggard, M.1
Guan, I.T.2
Edwards, K.3
-
34
-
-
0035213983
-
Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier
-
Y.H. Kim, S.H. Gihm, and C.R. Park Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier Bioconjug Chem 12 2001 932
-
(2001)
Bioconjug Chem
, vol.12
, pp. 932
-
-
Kim, Y.H.1
Gihm, S.H.2
Park, C.R.3
-
35
-
-
0034601856
-
Galactosylated chitosan-graft-dextran as hepatocyte-targeting DNA carrier
-
I.K. Park, Y.H. Park, and B.A. Shin Galactosylated chitosan-graft-dextran as hepatocyte-targeting DNA carrier J Control Release 69 2000 97
-
(2000)
J Control Release
, vol.69
, pp. 97
-
-
Park, I.K.1
Park, Y.H.2
Shin, B.A.3
-
36
-
-
0035801903
-
Mechanism of cell transfection with plasmid/chitosan complexes
-
T. Ishii, Y. Okahata, and T. Sato Mechanism of cell transfection with plasmid/chitosan complexes Biochim Biophys Acta 1514 2001 51
-
(2001)
Biochim Biophys Acta
, vol.1514
, pp. 51
-
-
Ishii, T.1
Okahata, Y.2
Sato, T.3
-
37
-
-
55149124541
-
Expression of human insulin gene wrapped with chitosan nanoparticles in NIH3T3 cells and diabetic rats
-
L. Niu, Y. Xu, and H. Xie Expression of human insulin gene wrapped with chitosan nanoparticles in NIH3T3 cells and diabetic rats Acta Pharmacol Sin 29 2008 1342
-
(2008)
Acta Pharmacol Sin
, vol.29
, pp. 1342
-
-
Niu, L.1
Xu, Y.2
Xie, H.3
-
38
-
-
33845635731
-
Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: Results of an in vitro and in vivo study
-
F. Zheng, X. Shi, and G. Yang Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: Results of an in vitro and in vivo study Life Sci 80 2007 388
-
(2007)
Life Sci
, vol.80
, pp. 388
-
-
Zheng, F.1
Shi, X.2
Yang, G.3
-
39
-
-
34250159823
-
Chitosan-thioglycolic acid conjugate: An alternative carrier for oral non-viral gene delivery?
-
R. Martien, B. Loretz, and M. Thaler Chitosan-thioglycolic acid conjugate: An alternative carrier for oral non-viral gene delivery? J Biomed Mater Res A 82 2007 1
-
(2007)
J Biomed Mater Res A
, vol.82
, pp. 1
-
-
Martien, R.1
Loretz, B.2
Thaler, M.3
-
41
-
-
35348855644
-
Limitations of green fluorescent protein as a cell lineage marker
-
E.S. Swenson, J.G. Price, and T. Brazelton Limitations of green fluorescent protein as a cell lineage marker Stem Cells 25 2007 2593
-
(2007)
Stem Cells
, vol.25
, pp. 2593
-
-
Swenson, E.S.1
Price, J.G.2
Brazelton, T.3
|